Thymoglobuline Powder for solution for infusion Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

thymoglobuline powder for solution for infusion

genzyme europe b.v., netherlands - rabbit anti human thymocyte immunoglobulin - powder for solution for infusion - 5 mg/ml,

AW FLAZZ 212 EC SELECTIVE HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aw flazz 212 ec selective herbicide

agri west pty limited - fluazifop-p present as the butyl ester; hydrocarbon solvent - emulsifiable concentrate - fluazifop-p present as the butyl ester phenoxy acids-propionics active 212.0 g/l; hydrocarbon solvent solvent other 685.0 g/l - herbicide - akee | apple | avocado | axillaris forage crop | axillaris seed crop | banana | bargoo jointvetch forage crop | bargoo jointvetc - annual grasses - see label | annual or wimmera ryegrass | annual phalaris | annual ryegrass | barley grass | barnyard or water grass | bent grass - established | brome grass | browntop bent | carpet grass | carpet grass - established | couch - seedling | couch grass | couch grass - established | crowsfoot grass | english couch - established | english couch - seedling | foxtail - seedling | green panic - seedling | green summer grass | guinea grass | guinea grass - established | innocent weed - seedling | innocent weed or grass | johnson grass | johnson grass - established | johnson grass - seedling | kentucky bluegrass - established | kikuyu grass | kikuyu grass - established | liverseed or urochloa grass | panic | para grass | para grass - established | paspalum | paspalum - established | paspalum - seedling | pasture | perennial grass weed | perennial grass weed - seedling | pigeon grass - seedling | prairie grass | rhodes grass | stink grass | summer grass | summer or crab grass | summer or crab grass - se

Siemens Atellica CH β2-Microglobulin (B2M) Singapore - English - HSA (Health Sciences Authority)

siemens atellica ch β2-microglobulin (b2m)

siemens healthcare pte. ltd. - clinical chemistry - the atellica ch β2-microglobulin (b2m) assay is for in vitro diagnostic use in the quantitative determination of β2-microglobulin in human serum and plasma (lithium heparin, potassium edta) using the atellica analyzer. the b2m assay aids in the diagnosis of active rheumatoid arthritis and kidney disease.

BORTEZOMIB EVER PHARMA bortezomib 3.5 mg/1.4 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bortezomib ever pharma bortezomib 3.5 mg/1.4 ml solution for injection vial

interpharma pty ltd - bortezomib, quantity: 3.5 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections; mannitol - bortezomib ever pharma, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib ever pharma, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib ever pharma is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib ever pharma in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

BORTEZOMIB EVER PHARMA bortezomib 2.5 mg/1 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bortezomib ever pharma bortezomib 2.5 mg/1 ml solution for injection vial

interpharma pty ltd - bortezomib, quantity: 2.5 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections; mannitol - bortezomib ever pharma, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib ever pharma, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib ever pharma is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib ever pharma in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

Rituzena (previously Tuxella) European Union - English - EMA (European Medicines Agency)

rituzena (previously tuxella)

celltrion healthcare hungary kft. - rituximab - lymphoma, non-hodgkin; microscopic polyangiitis; leukemia, lymphocytic, chronic, b-cell; wegener granulomatosis - antineoplastic agents - rituzena is indicated in adults for the following indications:non-hodgkin’s lymphoma (nhl)rituzena is indicated for the treatment of previously untreated patients with stage iii iv follicular lymphoma in combination with chemotherapy.rituzena monotherapy is indicated for treatment of patients with stage iii iv follicular lymphoma who are chemo resistant or are in their second or subsequent relapse after chemotherapy.rituzena is indicated for the treatment of patients with cd20 positive diffuse large b cell non hodgkin’s lymphoma in combination with chop (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy.chronic lymphocytic leukaemia (cll)rituzena in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory cll. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including rituzenaor patients refractory to previous rituzena plus chemotherapy.granulomatosis with polyangiitis and microscopic polyangiitisrituzena, in combination with glucocorticoids, is indicated for the induction of remission in adult patients with severe, active granulomatosis with polyangiitis (wegener’s) (gpa) and microscopic polyangiitis (mpa).

AC CHOP 500 INSECTICIDE AND TERMITICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ac chop 500 insecticide and termiticide

axichem pty ltd - chlorpyrifos; liquid hydrocarbon - emulsifiable concentrate - chlorpyrifos organophosphorus active 500.0 g/l; liquid hydrocarbon solvent other 488.0 g/l - insecticide - apple | asparagus | banana | bean | beetroot | broccoli | brussels sprouts | buildings - around | cabbage | canola | canola oils - african black beetle | ant | argentine ant | argentine stem weevil | australian plague locust | banana scab moth | banana weevil borer | black beetle | blackheaded pasture cockchafer | blue oat or pea mite | bluegreen aphid | brown pasture looper | cabbage aphid | cabbage cluster caterpillar | cabbage moth | cabbage white butterfly | california red scale | caterpillar | cluster caterpillar | cockroach infestation - heavy/residual | cockroach infestation - light | common armyworm | corn aphid | corn earworm | cotton aphid | cricket | cutworm | cutworm in young plants | false wireworm | flea - outdoors only | funnel ant | grapevine moth | grapevine scale | green peach aphid | green vegetable bug | hide beetle - dermestes ater | lawn armyworm | light brown apple moth | lucerne flea | lucerne leafroller | migratory locust | mosquito | mosquito larva | native budworm or bollworm | northern armyworm - mythimna separata | pasture webworm | pea aphid | pineapple mealy bug | redlegged earth mite | rice bloodworm | san

AC FLARE 212 HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ac flare 212 herbicide

axichem pty ltd - fluazifop-p present as the butyl ester; hydrocarbon solvent - emulsifiable concentrate - fluazifop-p present as the butyl ester phenoxy acids-propionics active 212.0 g/l; hydrocarbon solvent solvent other 685.0 g/l - herbicide - akee | apple | avocado | axillaris forage crop | axillaris seed crop | banana | bargoo jointvetch forage crop | bargoo jointvetc - annual grasses - see label | annual or wimmera ryegrass | annual phalaris | annual ryegrass | barley grass | barnyard or water grass | bent grass - established | brome grass | browntop bent | carpet grass | carpet grass - established | couch - seedling | couch grass | couch grass - established | crowsfoot grass | english couch - established | english couch - seedling | foxtail - seedling | green panic - seedling | green summer grass | guinea grass | guinea grass - established | innocent weed - seedling | innocent weed or grass | johnson grass | johnson grass - established | johnson grass - seedling | kentucky bluegrass - established | kikuyu grass | kikuyu grass - established | liverseed or urochloa grass | panic | para grass | para grass - established | paspalum | paspalum - established | paspalum - seedling | pasture | perennial grass weed | perennial grass weed - seedling | pigeon grass - seedling | prairie grass | rhodes grass | stink grass | summer grass | summer or crab grass | summer or crab grass - se

Arzerra European Union - English - EMA (European Medicines Agency)

arzerra

novartis europharm ltd - ofatumumab - leukemia, lymphocytic, chronic, b-cell - monoclonal antibodies - previously untreated chronic lymphocytic leukaemia (cll): arzerra in combination with chlorambucil or bendamustine is indicated for the treatment of patients with cll who have not received prior therapy and who are not eligible for fludarabine-based therapy. relapsed cll: arzerra is indicated in combination with fludarabine and cyclophosphamide for the treatment of adult patients with relapsed cll. refractory cll: arzerra is indicated for the treatment of cll in patients who are refractory to fludarabine and alemtuzumab.,

CERTICAN  0.5 MG TABLETS Israel - English - Ministry of Health

certican 0.5 mg tablets

novartis israel ltd - everolimus - tablets - everolimus 0.5 mg - everolimus - everolimus - kidney and heart transplantationcertican ® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in adult patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.